Compare Southwest Airlines Co (LUV) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Southwest Airlines Co vs State Street SPDR S&P Biotech ETF — how do they compare? Southwest Airlines Co trades at $45.21 (market cap $22.27B), while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: Southwest Airlines Co pays a 1.58% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Southwest Airlines Co nearer its low. Which is the better fit depends on your goals.
| LUV | XBI | |
|---|---|---|
Market Cap | $22.27B | — |
Sector | Industrials | Broad Market / Factor |
52-Week High | $54.80 | $164.28 |
52-Week Low | $29.67 | $86.92 |
Enterprise Value | $25.37B | — |
Dividend Yield | 1.58% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Southwest Airlines Co
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
